Elena Rampanelli
Overview
Explore the profile of Elena Rampanelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1094
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blok L, Hanssen N, Nieuwdorp M, Rampanelli E
Metabolites
. 2025 Feb;
15(2).
PMID: 39997763
Type 1 diabetes (T1D) is a severe chronic T-cell mediated autoimmune disease that attacks the insulin-producing beta cells of the pancreas. The multifactorial nature of T1D involves both genetic and...
2.
Rampanelli E, Romp N, Troise A, Ananthasabesan J, Wu H, Gul I, et al.
Microbiome
. 2025 Jan;
13(1):15.
PMID: 39833973
Background: The human gut microbiome strongly influences host metabolism by fermenting dietary components into metabolites that signal to the host. Our previous work has shown that Intestinimonas butyriciproducens is a...
3.
Warmbrunn M, Attaye I, Horak A, Banerjee R, Massey W, Varadharajan V, et al.
NPJ Biofilms Microbiomes
. 2024 Nov;
10(1):118.
PMID: 39496629
Imidazole Propionate (ImP), a gut-derived metabolite from histidine, affects insulin signaling in mice and is elevated in type 2 diabetes (T2D). However, the source of histidine and the role of...
4.
Scheithauer T, Wortelboer K, Winkelmeijer M, Verdoes X, Aydin O, Acherman Y, et al.
Gut Microbes
. 2024 Jul;
16(1):2380747.
PMID: 39068518
Individuals with type 2 diabetes (T2D) show signs of low-grade inflammation, which is related to the development of insulin resistance and beta-cell dysfunction. However, the underlying triggers remain unknown. The...
5.
Verhaar B, Wijdeveld M, Wortelboer K, Rampanelli E, Levels J, Collard D, et al.
Hypertension
. 2024 Jul;
81(10):2124-2136.
PMID: 39034917
Background: The microbiota-derived short chain fatty acid butyrate has been shown to lower blood pressure (BP) in rodent studies. Nonetheless, the net effect of butyrate on hypertension in humans remains...
6.
de Wit D, Fuhri Snethlage C, Rampanelli E, Maasen K, Walpot N, van Raalte D, et al.
Diabetologia
. 2024 Jul;
67(10):2199-2209.
PMID: 38967668
Aims/hypothesis: The aim of this work was to investigate the association between macronutrient intakes and continuous glucose monitoring (CGM) metrics in individuals with type 1 diabetes. Methods: In 470 individuals...
7.
Warmbrunn M, Attaye I, Aron-Wisnewsky J, Rampanelli E, van der Vossen E, Hao Y, et al.
Gut Microbes
. 2024 Jul;
16(1):2370616.
PMID: 38961712
Amino acids, metabolized by host cells as well as commensal gut bacteria, have signaling effects on host metabolism. Oral supplementation of the essential amino acid histidine has been shown to...
8.
Fuhri Snethlage C, Balvers M, Ferwerda B, Rampanelli E, de Groen P, Roep B, et al.
Diabetologia
. 2024 Jun;
67(9):1865-1876.
PMID: 38922416
Aims/hypothesis: Use of genetic risk scores (GRS) may help to distinguish between type 1 diabetes and type 2 diabetes, but less is known about whether GRS are associated with disease...
9.
Fuhri Snethlage C, de Wit D, Wortelboer K, Rampanelli E, Hanssen N, Nieuwdorp M
Immunol Rev
. 2024 May;
325(1):46-63.
PMID: 38752578
Type 1 diabetes (T1D) is a chronic autoimmune disease targeting insulin-producing pancreatic beta cells. T1D is a multifactorial disease incorporating genetic and environmental factors. In recent years, the advances in...
10.
Fuhri Snethlage C, Meijnikman A, Mak A, Rampanelli E, Voermans B, Callender C, et al.
Eur J Endocrinol
. 2024 Apr;
190(5):391-400.
PMID: 38679966
Aims/hypothesis: The prevalence and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in type 1 diabetes remain unclear. Therefore, we investigated the prevalence and severity of MASLD in type 1...